New Ocular Telehealth Program Enabling Diabetic Retinopathy Screening

 New Ocular Telehealth Program Enabling Diabetic Retinopathy Screening

Visionix USA and 20/20NOW announce the launch of their newest collaboration, an Ocular Telehealth Program that will be presented at the American Telemedicine Association (ATA)’s 2024 Nexus Conference and Expo in Arizona this May. Visionix and 20/20NOW will be offering an exclusive exploration on how to get started with telehealth-enabled eye exams at ATA booth #814. Slots are limited so ATA attendees are encouraged to book an appointment. One-on-one consultations will be available to learn about:

  • How to get started with Ocular Telehealth,
  • Establishing a Comprehensive Screening Program,
  • Exploring Visual Tools for Diabetic Retinopathy patient consultations,
  • Understanding Legal, IT and EMR compatibility; as well as ROI, staffing and OPEX considerations.

Addressing the need for early detection of Diabetic Retinopathy (and more)

recent report by Yale University concluded that the prevalence of diabetes-related eye disease  remains high yet an estimated 50% of patients with diabetes do not receive recommended annual vision screening, while JAMA Ophthalmology estimated 9.6 million people in the United States have DR. 

According to Matt Vulich, VP National Accounts & Optical Sales at Visionix USA, “The strategic purpose of  our technology partnership is to help more providers provide high-quality eye exams to more patients.  Diabetic Retinopathy ― or DR ― can have life-changing impact, and we can help more doctors prevent  or identify symptoms in its early stages. I am proud to share that our new Ocular Telehealth Program with  20/20NOW offers several Visionix device options—from straightforward retinal screening to  comprehensive multimodal screening of eye diseases.”

Click here to read the full press release

Source: Visionix

  • <<
  • >>

Comments